Several pathways are deregulated in intrahepatic CCA, including IL-6/STAT3 signaling and growth factors such as EGF, HGF/MET, and VEGF, and the KRAS/MAPK and PI3K/AKT pathways [6-8]. This evidence concerns the gene AKT1 and cholangiocarcinoma.